RELA and type 2 diabetes mellitus: Interestingly, a recent investigation has shown that dapagliflozin can reduce the shift of p65 to the nucleus, which can be beneficial for the suppression of STZ-induced cardiac hypertrophy in a rat model of T2DM [53].